← 返回

OLR1 是乳腺癌的预后因素并与免疫浸润相关

英文原题:OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.

查看英文原题

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.

PubMed 2021/10/21(内容时间) Int Immunopharmacol Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

氧化低密度脂蛋白受体1(OLR1)是氧化低密度脂蛋白(ox-LDL)的关键受体,在癌症和炎症性疾病中发挥重要作用。然而,OLR1表达与乳腺癌(BC)免疫浸润之间的相关性仍不清楚。

在本研究中,我们通过实时荧光定量PCR、免疫组化分析和不同数据库,全面分析了BC组织中OLR1的表达水平,并探讨了OLR1的预后意义。通过LinkedOmics分析,利用显著富集的KEGG和GO通路来识别OLR1的潜在生物学功能。

此外,我们通过肿瘤免疫估计资源数据库和GEPIA数据库检测了OLR1表达与多种免疫浸润细胞之间的相关性。我们的研究揭示,BC组织中观察到OLR1上调,并与较差的临床结局和晚期临床病理因素相关。

同时,OLR1调控多种免疫相关通路,尤其是巨噬细胞的极化。免疫组化分析进一步证实了OLR1表达与M2巨噬细胞及肿瘤相关巨噬细胞的肿瘤浸润之间存在显著相关性。OLR1上调提示BC预后不良,可能通过诱导巨噬细胞极化和触发免疫逃逸实现。总之,OLR1可能代表BC个体化治疗的潜在治疗靶点。

展开英文摘要原文

Oxidized low-density lipoprotein receptor 1 (OLR1), a key receptor for oxidized low-density lipoprotein (ox-LDL), plays a crucial role in cancer and inflammatory disease.

However, the correlation between OLR1 expression and immune infiltration in breast cancer (BC) remain unclear. In this study, we comprehensively analyzed the expression level of OLR1 in BC tissues and explore the prognostic importance of OLR1 using quantitative real-time PCR, immunohistochemical analysis and different databases. The significantly enriched KEGG and GO pathways were used to identify the potential biological function of OLR1 via LinkedOmics analysis.

Furthermore, we detected the correlation between OLR1 expression and a variety of immune infiltrating cells via Tumor Immune Estimation Resource database and GEPIA database.

Our study revealed that OLR1 upregulation was observed in BC tissues and correlated with worse clinical outcomes and advanced clinicopathological factors. Meanwhile, OLR1 regulated various immunity-related pathways, especially the polarization of macrophages.

Immunohistochemical analysis further confirmed the significant correlation between OLR1 expression and tumor infiltration of M2 macrophages as well as tumor-associated macrophages. OLR1 upregulation indicated poor prognosis in BC, possibly through inducing macrophage polarization and triggering immune evasion. Collectively, OLR1 may represent a potential therapeutic target for BC tailored therapy.

论文信息

作者
Sun X、Fu X、Xu S、Qiu P、Lv Z、Cui M、Zhang Q、Xu Y
第一作者单位
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.China
通讯作者单位
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China. Electronic address: xuyingying@cmu.edu.cn.China
期刊
International immunopharmacology2021 Dec
原文标识
PubMed 34688153 · DOI 10.1016/j.intimp.2021.108275